Quest Diagnostics Inc (NYSE:DGX)

During the Trading Day
62.77 +0.23 / +0.37%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
62.77 0.00 / 0.00%
 
Volume: 2.1K
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$9.0B

Company Description

Quest Diagnostics, Inc. is engaged in providing diagnostic testing, information and services that help patients, physicians and others to make better healthcare decisions. It offers patients and physicians the broadest access to diagnostic laboratory services through the company's nationwide network of laboratories and patient service centers. The company's services range from routine blood tests such as cholesterol, Pap testing and white blood cell counts to cancer testing as well as gene-based and molecular testing. It also offers clinical testing, which include gene-based and esoteric testing, anatomic pathology services and testing for drugs-of-abuse in the United States, and risk assessment services for the life insurance industry in North America and also manufactures and markets diagnostics products like diagnostic test kits and specialized point-of-care testing equipment. The company empowers healthcare organizations and clinicians with information technology solutions that can improve patient care and medical practice. Its non-clinical testing businesses consist of its risk assessment services, clinical trials testing, healthcare information technology, and diagnostics products businesses. The company's risk assessment services business provides underwriting support services to the life insurance industry, which include specimen collection and paramedical examinations, laboratory testing, medical record retrieval, case management, motor vehicle reports, telephone inspections, prescription histories and credit checks. Its clinical trials testing business provides clinical testing performed in connection with clinical research trials on new drugs, vaccines and certain medical devices. The company's healthcare information technology business is a developer and integrator of clinical connectivity and data management solutions for healthcare organizations, physicians and clinicians that can help improve patient care and medical practice. Its diagnostics products business manufactures and markets products that enable healthcare professionals to make healthcare diagnoses, including products for point-of-care testing for the professional market. The company's Life Insurer services business provides risk assessment services to the life insurance industry in North America. Quest Diagnostics was spun off from the Corning, Inc. as an independent company on December 31, 1996. Quest Diagnostics was founded by Paul A. Brown in 1967 and is headquartered in Madison, NJ.

Contact Information

Quest Diagnostics, Inc.
3 Giralda Farms
Madison New Jersey 07940
P:(973) 520-2700
Investor Relations:
(973) 520-2800

Employees

Shareholders

Mutual fund holders53.61%
Other institutional51.65%
Individual stakeholders26.48%

Top Executives

Stephen H. RusckowskiPresident, Chief Executive Officer & Director
James E. DavisSenior Vice President-Operations
Mark J. GuinanChief Financial Officer & Senior Vice President
David EvansVice President-Information Technology
Jon Roger CohenChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.